Critical illnesses including sepsis, acute respiratory distress syndromes, ischemic
cardiovascular disorders and acute organ injuries are associated with high mortality …

The transplantation of mesenchymal stem cells (MSCs) for treating neurodegenerative
disorders has received growing attention recently because these cells are readily available …

In recent decades, human mesenchymal stem cells (hMSCs) have gained momentum in the
field of cell therapy for treating cartilage and bone injuries. Despite the tri-lineage …

Background. Human mesenchymal stromal/stem cells (hMSCs) hold great therapeutic
potential due to their immunomodulatory and tissue regenerative properties. Enhancement …

Peripheral artery disease (PAD) is a debilitating and prevalent condition characterized by
blockage of the arteries, leading to limb amputation in more severe cases. Mesenchymal …

Stem cells are poorly permissive to non‐viral gene transfection reagents. In this study, we
explored the possibility of improving gene delivery into human embryonic (hESC) and …

As a promising strategy to aid or replace tissue/organ transplantation, gene delivery has
been used for regenerative medicine applications to create or restore normal function at the …

Mesenchymal stem/stromal cells (MSCs) are not only capable of self-renewal, trans-
differentiation, homing to damaged tissue sites and immunomodulation by secretion of …

To solve problems in polymersome preparation caused by liposolubility of copolymers and
to improve the cytosolic delivery efficiency of polymersomes to drugs, a lipopolysaccharide …

Bone marrow stromal cells (BMSCs) have proven useful for the treatment of various human
diseases and injuries. However, their reparative capacity is limited by their poor migration …